Research output per year
Research output per year
Fingerprint
The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
- 1 Similar Profiles
Network
Dive into details by clicking on the dots.
Research output
-
Dansk Myelomatose Database – Resumé af årsrapport 2021
Hermansen, E., Kristensen, I. B., Gregersen, H., Klostergaard, A., Jensen, B. A., Dravecká, J., Hinge, M., Pedersen, R. S., Pedersen, P. T., Christiansen, N. M., Fredsted, A. & Steding-Jessen, M., 9 Feb 2023, (E-pub ahead of print) In: Ugeskrift for Laeger.Research output: Contribution to journal › Journal article › Communication
-
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation
Bertelsen, L. D., Børty Nielsen, L., Christensen, H. S., Bøgsted, M., Gregersen, H., Pedersen, R. S., Klostergaard, A., Schnack, B. I., Pedersen, P. T., Abildgaard, N., Hermansen, E., Vangsted, A. J. & Severinsen, M. T., Mar 2023, In: European Journal of Haematology. 110, 3, p. 289-295 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open Access -
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M., & 1 others, Jan 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus)16 Downloads (Pure) -
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A., Brøndum, R. F., Johnsen, H. E., Mellqvist, U-H., Waage, A., Gimsing, P., Op Bruinink, D. H., van der Velden, V., van der Holt, B., Hansson, M., Andersen, N. F., Frølund, U. C., Helleberg, C., Schjesvold, F. H., Ahlberg, L., Gulbrandsen, N., Andreasson, B., Lauri, B., Haukas, E., Bødker, J. S., & 7 others, 5 Feb 2022, In: BMC Cancer. 22, 1, 147.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile11 Downloads (Pure) -
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
Blimark, C. H., Vangsted, A. J., Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), Feb 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus)
Activities
-
Bestyrelsen i Dansk Hæmatologisk Selskab (DHS) (External organisation)
Henrik Gregersen (Member)
1 Mar 2011 → …Activity: Memberships › Board duties in companies, associations, or public organisations
-
52nd Annual Meeting and Exposition of the American Society of Hematology
Henrik Gregersen (Participant)
4 Dec 2010 → 7 Dec 2010Activity: Attending an event › Conference organisation or participation
-
Risikofaktorer for DVT og deres betydning for varigheden af AK-behandling
Henrik Gregersen (Lecturer)
23 Nov 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Staff Meeting, Aalborg Sygehus, Auditoriet i Medicinerhuset
Henrik Gregersen (Speaker)
23 Nov 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Myelomatose: Fra diagnostik til behandling
Henrik Gregersen (Lecturer)
10 Sept 2010Activity: Talks and presentations › Talks and presentations in private or public companies
Press/Media
-
Godkendt mod knoglemarvskræft i EU: "Det er begyndelsen på en ny, stor behandlingsbølge, som kan revolutionere behandlingen"
27/09/2022
2 items of Media coverage
Press/Media: Press / Media
-
Carfilzomib forlænger tiden til tilbagefald for patienter med myelomatose
10/12/2019
1 item of Media coverage
Press/Media: Press / Media